Skip to main content
SpringerLink
Log in

Rotavirus vaccination seems to have been cost saving in the USA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Newall AT, et al. Rotavirus vaccination likely to be cost saving to society in the United States. . Clinical Infectious Diseases : 26 May 2021. Available from: URL: http://doi.org/10.1093/cid/ciab442

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rotavirus vaccination seems to have been cost saving in the USA. PharmacoEcon Outcomes News 880, 26 (2021). https://doi.org/10.1007/s40274-021-7784-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7784-y

Search

Navigation